Symbol="FOLD"
AssetType="Common Stock"
Name="Amicus Therapeutics Inc"
Description="Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania."
CIK="1178879"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 CEDAR BROOK DRIVE, CRANBURY, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3861696000"
EBITDA="-166712000"
PERatio="None"
PEGRatio="-0.18"
BookValue="0.362"
DividendPerShare="0"
DividendYield="0"
EPS="-0.68"
RevenuePerShareTTM="1.162"
ProfitMargin="-0.606"
OperatingMarginTTM="-0.51"
ReturnOnAssetsTTM="-0.141"
ReturnOnEquityTTM="-1.197"
RevenueTTM="336788000"
GrossProfitTTM="290634000"
DilutedEPSTTM="-0.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.096"
AnalystTargetPrice="15.9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.51"
PriceToBookRatio="24.77"
EVToRevenue="10.46"
EVToEBITDA="-15.91"
Beta="0.832"
num_52WeekHigh="13.85"
num_52WeekLow="9.1"
num_50DayMovingAverage="12.5"
num_200DayMovingAverage="11.96"
SharesOutstanding="284576000"
DividendDate="None"
ExDividendDate="None"
symbol="FOLD"
open="13.33"
high="13.61"
low="13.23"
price="13.57"
volume="3776198.00"
latest_trading_day="2023-07-28"
previous_close="13.25"
change="0.32"
change_percent="2.4151%"
aroon_positive_momentum_days="48"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="2465860"
Change_recent_avg="0.01"
Delta_recent_avg="0.39"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="519"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="657"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0051.jpeg"
image_positive_thumbnail_id_2="673"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
